Alemtuzumab as treatment for residual disease after chemotherapy in patients with chronic lymphocytic leukemia
暂无分享,去创建一个
H. Kantarjian | J. Cortes | M. Keating | S. O'brien | F. Giles | M. Albitar | W. Wierda | A. Ferrajoli | S. Lerner | C. Koller | D. Thomas | M. Browning | Mary L. Browning